Gemina Laboratories Ltd. (CSE:GLAB)
Canada · Delayed Price · Currency is CAD 0.7500
+0.0700 (10.29%)
Jul 30, 2025, 3:56 PM EDT
Ligand Pharmaceuticals Market Cap
Gemina Laboratories has a market cap or net worth of CAD 57.43 million as of August 1, 2025. Its market cap has increased by 63.16% in one year.
Market Cap
57.43M
Enterprise Value
57.66M
Revenue
10.88K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.75
Market Cap Chart
Since August 11, 2021, Gemina Laboratories's market cap has increased from 21.35M to 57.43M, an increase of 168.97%. That is a compound annual growth rate of 28.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 57.43M | -2.90% |
| Dec 27, 2024 | 59.14M | 49.36% |
| Dec 29, 2023 | 39.60M | 23.55% |
| Dec 30, 2022 | 32.05M | 49.59% |
| Dec 29, 2021 | 21.43M | 0.35% |
| Aug 11, 2021 | 21.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.16B |
| Sienna Senior Living | 1.65B |
| dentalcorp Holdings | 1.57B |
| Curaleaf Holdings | 1.50B |
| Trulieve Cannabis | 1.24B |
| WELL Health Technologies | 1.17B |
| Cronos Group | 1.04B |
| Extendicare | 1.03B |